--2025/Q2-- / 2.492M--
--2025/Q1-- / 2.492M--
--2024/Q4412.000K / 393.750K--
--2024/Q3516.000K / 242.220K--
--2024/Q21.254M / 54.313M--
Strategy
MSTR
Coinbase
COIN
Tesla
TSLA
Vale SA
VALE
NVIDIA
NVDA
US Stock MarketDetailed Quotes
IGMS IGM Biosciences
- 1.390
- +0.050+3.73%
Close Mar 11 16:00 ET
- 1.390
- 0.0000.00%
Post 16:05 ET
83.09MMarket Cap-0.43P/E (TTM)
1.418High1.290Low197.67KVolume1.350Open1.340Pre Close267.83KTurnover1.85%Turnover RatioLossP/E (Static)59.78MShares22.50052wk High1.72P/B14.84MFloat Cap1.18752wk Low--Dividend TTM10.68MShs Float133.000Historical High--Div YieldTTM9.53%Amplitude1.187Historical Low1.354Avg Price1Lot Size
IGM Biosciences Key Stats
IGM Biosciences Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
IGM Biosciences Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data